
|Podcasts|June 17, 2022
Pharmacy Focus: Psychedelic Pharmacy - Psilocybin-Assisted Therapy for Binge Eating Disorder
Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.
Advertisement
This month, we spoke with Jim Gilligan, PhD, to learn about a phase 2 study investigating the use of psilocybin-assisted therapy for the treatment of binge eating disorder.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5


























